The putative mechanisms of let7 down-regulation in cancer include not only genetic alterations, but also regulation of RAS and MYC oncogenes, direct targeting of DICER mRNA and cell proliferation control in a cyclin-dependent manner [58]. The gene discussed is MYC; the disease is cancer.